MWA
CVS icon

Marshall Wace Asia’s CVS Health CVS Stock Holding History

Marshall Wace Asia’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-41,890
Closed -$2.48M – 124
2020
Q1 		$2.48M Buy
+41,890
New +$2.8M 0.07% 55
2019
Q1 		– Sell
-50,640
Closed -$3.32M – 104
2018
Q4 		$3.32M Buy
+50,640
New +$3.78M 0.12% 73
2018
Q3 		– Sell
-70,219
Closed -$4.52M – 96
2018
Q2 		$4.52M Buy
+70,219
New +$4.63M 0.15% 70

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Marshall Wace Asia's CVS Position: Q2 2020 in Review

Marshall Wace Asia sold out of CVS Health (CVS) in Q2 2020, closing a stake of 41,890 shares — an estimated $2.48M sold.

Marshall Wace Asia first reported a position in CVS in Q2 2018 and held it in 3 quarters. The position peaked at $4.52M in Q2 2018. 1,863 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • Marshall Wace Asia reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
  • Marshall Wace Asia sold 41,890 CVS Health shares in Q2 2020, an estimated $2.48M.
  • Marshall Wace Asia first reported a position in CVS Health in Q2 2018 and held it in 3 quarters.
  • Marshall Wace Asia's CVS Health position peaked at $4.52M in Q2 2018.
  • 1,863 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on Marshall Wace Asia's 13F filing for Q2 2020, filed 13 Aug 2020.